| P2093 | author name string | Stephan Köhler | |
| | Philipp Sterzer | |
| | Felix Betzler | |
| | Laura Apollonia Stöver | |
| P2860 | cites work | DSM-5 | Q3064664 |
| | Bipolar Mixed States: An International Society for Bipolar Disorders Task Force Report of Symptom Structure, Course of Illness, and Diagnosis | Q22241856 |
| | Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis | Q22242068 |
| | Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placebo-Controlled Clinical Trials | Q28074759 |
| | A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state | Q28730355 |
| | Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile | Q34020949 |
| | Dissimilar morbidity following initial mania versus mixed-states in type-I bipolar disorder | Q34077437 |
| | Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders | Q34106678 |
| | Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: results from post hoc analyses | Q34292519 |
| | Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-analysis of placebo-controlled trials | Q34348604 |
| | Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study | Q34474219 |
| | Pharmacotherapy of manic-depressive mixed States | Q34498972 |
| | Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis | Q34744822 |
| | Subthreshold bipolarity: diagnostic issues and challenges | Q36096615 |
| | Bipolar disorder--focus on bipolar II disorder and mixed depression | Q36762989 |
| | Epidemiology, diagnosis and management of mixed mania | Q36881398 |
| | Pure and mixed manic subtypes: a review of diagnostic classification and validation | Q37058576 |
| | Lamotrigine: when and where does it act in affective disorders? A systematic review | Q37786119 |
| | Differences and overlap in self-reported symptoms of bipolar disorder and borderline personality disorder | Q47945320 |
| | Clinical subtypes of severe bipolar mixed states | Q47974662 |
| | Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study | Q48070817 |
| | Making sense of DSM-5 mania with depressive features | Q48083750 |
| | A 13-week, randomized double-blind, placebo-controlled, cross-over trial of ziprasidone in bipolar spectrum disorder. | Q48085355 |
| | Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392). | Q48258866 |
| | Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder | Q48373114 |
| | Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study | Q48407645 |
| | Are bipolar disorders underdiagnosed in patients with depressive episodes? Results of the multicenter BRIDGE screening study in Germany | Q48616359 |
| | A randomized, placebo- and active-controlled study of paliperidone extended-release as maintenance treatment in patients with bipolar I disorder after an acute manic or mixed episode | Q48721347 |
| | Signs and symptoms of mania in pure and mixed episodes | Q48777412 |
| | Mania and depression. Mixed, not stirred. | Q48883016 |
| | Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial | Q50246045 |
| | Depression during mania. Treatment response to lithium or divalproex. | Q50978467 |
| | Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. | Q51899995 |
| | The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention. | Q53260493 |
| | Treatment of mixed bipolar states | Q37973144 |
| | DSM-5 criteria for depression with mixed features: a farewell to mixed depression | Q38100235 |
| | A reevaluation of the possibility and characteristics in bipolar mania with mixed features: a retrospective chart review | Q38169354 |
| | The challenge of treatment in bipolar depression: evidence from clinical guidelines, treatment recommendations and complex treatment situations | Q38189299 |
| | Bipolar or borderline: a clinical overview | Q38191252 |
| | The significance of mixed states in depression and mania | Q38241136 |
| | Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study | Q38378764 |
| | Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial | Q38413840 |
| | Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study | Q38418204 |
| | Comorbidity between bipolar disorder and borderline personality disorder: Prevalence, explanatory theories, and clinical impact | Q38856645 |
| | First controlled treatment trial of bipolar II hypomania with mixed symptoms: quetiapine versus placebo | Q39122231 |
| | Mixed state discrimination: a DSM problem that won׳t go away? | Q39225665 |
| | Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study. | Q39351057 |
| | Suicide attempts in major depressive episode: evidence from the BRIDGE-II-Mix study. | Q40490409 |
| | Electroconvulsive therapy in 197 patients with a severe, drug-resistant bipolar mixed state: treatment outcome and predictors of response | Q40980482 |
| | Incidence and significance of mixed affective states in a bipolar population | Q41060594 |
| | Effects of asenapine in bipolar I patients meeting proxy criteria for moderate-to-severe mixed major depressive episodes: a post hoc analysis | Q41543014 |
| | Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder | Q42605096 |
| | Safety and efficacy of olanzapine in the long-term treatment of Japanese patients with bipolar I disorder, depression: an integrated analysis. | Q42637388 |
| | Relative effectiveness of adjunctive risperidone on manic and depressive symptoms in mixed mania | Q42680862 |
| | A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder | Q43011129 |
| | Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis | Q43244285 |
| | A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states | Q43258938 |
| | Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group | Q43507067 |
| | Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy | Q43846648 |
| | Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. | Q43867164 |
| | DSM-5-defined 'mixed features' and Benazzi's mixed depression: which is practically useful to discriminate bipolar disorder from unipolar depression in patients with depression? | Q44107642 |
| | Acute dysphoric mania: treatment response to olanzapine versus placebo | Q44364152 |
| | Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial | Q44385585 |
| | Efficacy of ziprasidone in dysphoric mania: pooled analysis of two double-blind studies | Q44392516 |
| | A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 |
| | Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients | Q44710965 |
| | Mixed states with predominant manic or depressive symptoms: baseline characteristics and 24-month outcomes of the EMBLEM cohort | Q44943396 |
| | Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania | Q45168960 |
| | Evidence-based definitions of bipolar-I and bipolar-II disorders among 5,635 patients with major depressive episodes in the Bridge Study: validity and comorbidity | Q45748197 |
| | Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episode | Q45750933 |
| | The symptom structure of bipolar acute episodes: in search for the mixing link. | Q45906308 |
| | Efficacy of olanzapine in the treatment of bipolar mania with mixed features defined by DSM-5. | Q45925307 |
| | Prevalence of mixed mania using 3 definitions | Q46120264 |
| | Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo | Q46547600 |
| | Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial | Q46596821 |
| | Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study | Q46669710 |
| | Risperidone in the treatment of acute mania: double-blind, placebo-controlled study | Q46681460 |
| | Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study | Q46886132 |
| | Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder | Q46975571 |
| | More inclusive bipolar mixed depression definition by permitting overlapping and non-overlapping mood elevation symptoms | Q47434798 |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 1-15 | |
| P577 | publication date | 2017-04-18 | |
| P1433 | published in | International Journal of Psychiatry in Clinical Practice | Q15746484 |
| P1476 | title | Mixed states in bipolar disorder - changes in DSM-5 and current treatment recommendations | |